Next Article in Journal
Oral Administration of Coronavirus Spike Protein Provides Protection to Newborn Pigs When Challenged with PEDV
Previous Article in Journal
Evaluating Rates and Determinants of COVID-19 Vaccine Hesitancy for Adults and Children in the Singapore Population: Strengthening Our Community’s Resilience against Threats from Emerging Infections (SOCRATEs) Cohort
Previous Article in Special Issue
Expanding Protection Motivation Theory to Explain Willingness of COVID-19 Vaccination Uptake among Taiwanese University Students
Article

“Until I Know It’s Safe for Me”: The Role of Timing in COVID-19 Vaccine Decision-Making and Vaccine Hesitancy

1
Disaster and Emergency Management, School of Administrative Studies, York University, Toronto, ON M3J 1P3, Canada
2
Politics & International Relations, School of Social and Political Science, University of Edinburgh, Edinburgh EH8 9YL, Scotland, UK
3
Discourse, Science, Publics Lab, Department of Psychology, University of Guelph, Guelph, ON N1G 2W1, Canada
*
Author to whom correspondence should be addressed.
Academic Editor: Ralph J. DiClemente
Vaccines 2021, 9(12), 1417; https://doi.org/10.3390/vaccines9121417
Received: 21 September 2021 / Revised: 6 November 2021 / Accepted: 13 November 2021 / Published: 30 November 2021
(This article belongs to the Special Issue Vaccination and Public Health Version II: COVID-19 Vaccination)
Managing the COVID-19 pandemic—and other communicable diseases—involves broad societal uptake of vaccines. As has been demonstrated, however, vaccine uptake is often uneven and incomplete across populations. This is a substantial challenge that must be addressed by public health efforts. To this point, significant research has focused on demographic and attitudinal correlates with vaccine hesitancy to understand uptake patterns. In this study, however, we advance understandings of individual decision-making processes involved in vaccine uptake through a mixed-methods investigation of the role of timing in COVID-19 vaccine choices. In the first step, a survey experiment, we find the timing of vaccine rollout (i.e., when a vaccine becomes available to the respondent) has a significant impact on public decision-making. Not only is there a higher level of acceptance when the vaccine becomes available at a later time, but delayed availability is correlated with both lower levels of ‘desire to wait’ and ‘total rejection’ of the vaccine. In a second step, we explore associated qualitative data, finding that temporal expressions (i.e., professing a desire to wait) can serve as a proxy for underlying non-temporal rationales, like concerns around safety, efficacy, personal situations, or altruism. By identifying these patterns, as well as the complexities of underlying factors, through a mixed-methods investigation, we can inform better vaccine-related policy and public messaging, as well as enhance our understanding of how individuals make decisions about vaccines in the context of COVID-19. View Full-Text
Keywords: vaccine; COVID-19; vaccine hesitancy; risk aversion; timing; public health vaccine; COVID-19; vaccine hesitancy; risk aversion; timing; public health
Show Figures

Figure 1

MDPI and ACS Style

Kennedy, E.B.; Daoust, J.-F.; Vikse, J.; Nelson, V. “Until I Know It’s Safe for Me”: The Role of Timing in COVID-19 Vaccine Decision-Making and Vaccine Hesitancy. Vaccines 2021, 9, 1417. https://doi.org/10.3390/vaccines9121417

AMA Style

Kennedy EB, Daoust J-F, Vikse J, Nelson V. “Until I Know It’s Safe for Me”: The Role of Timing in COVID-19 Vaccine Decision-Making and Vaccine Hesitancy. Vaccines. 2021; 9(12):1417. https://doi.org/10.3390/vaccines9121417

Chicago/Turabian Style

Kennedy, Eric B., Jean-François Daoust, Jenna Vikse, and Vivian Nelson. 2021. "“Until I Know It’s Safe for Me”: The Role of Timing in COVID-19 Vaccine Decision-Making and Vaccine Hesitancy" Vaccines 9, no. 12: 1417. https://doi.org/10.3390/vaccines9121417

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop